Effectiveness of Antihypertensive Medications in Office and Ambulatory Settings: A Placebo‐Controlled Comparison of Atenolol, Metoprolol, Chlorthalidone, Verapamil, and an Atenolol‐Chlorthalidone Combination
暂无分享,去创建一个
[1] M. D. De Buyzere,et al. Prognostic value of ambulatory blood pressure monitoring. , 1994, Journal of hypertension.
[2] L. Fisher,et al. Once‐Daily Verapamil in the Treatment of Mild‐to‐Moderate Hypertension: A Double‐Blind Placebo‐Controlled Dose‐Ranging Study , 1991, Journal of clinical pharmacology.
[3] R B D'Agostino,et al. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. , 1990, The New England journal of medicine.
[4] H. Rüddel,et al. Disparities in blood pressure control under various antihypertensive regimens. , 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[5] N. Schneiderman,et al. Predicting home and work blood pressure measurements from resting baselines and laboratory reactivity in black and white Americans. , 1989, Psychophysiology.
[6] W. White,et al. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. , 1989, JAMA.
[7] M. Weber,et al. Characterization of antihypertensive therapy by whole-day blood pressure monitoring. , 1988, JAMA.
[8] G. Waeber,et al. Comparison of betaxolol with verapamil in hypertensive patients: discrepancy between office and ambulatory blood pressures. , 1988, Journal of hypertension.
[9] J. Laragh,et al. How common is white coat hypertension? , 1988, JAMA.
[10] R. Devereux,et al. Ambulatory monitoring of blood pressure as a predictor of cardiovascular risk. , 1987, American heart journal.
[11] G Parati,et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. , 1987, Journal of hypertension.
[12] W. White,et al. Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension. , 1986, Journal of the American College of Cardiology.
[13] S. Sheps,et al. Verapamil and 24-hour ambulatory blood pressure monitoring in essential hypertension. , 1986, The American journal of cardiology.
[14] F. Martinez,et al. Comparative study of the antihypertensive effect of verapamil and atenolol. , 1986, The American journal of cardiology.
[15] B. Masse,et al. Antihypertensive therapy with calcium-channel blockers: Comparison with beta blockers , 1985 .
[16] L. Cubeddu,et al. Verapamil and propranolol in essential hypertension , 1984, Clinical pharmacology and therapeutics.
[17] J S Borer,et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. , 1983, Circulation.
[18] M. Sokolow,et al. The prognostic value of ambulatory blood pressures. , 1983, JAMA.
[19] D. Sherrard,et al. Blood pressure reductions during self-recording of home blood pressure. , 1979, American heart journal.
[20] G. Pickering,et al. Hypertension. Definitions, natural histories and consequences. , 1972, The American journal of medicine.
[21] M. Sokolow,et al. Relationship Between Level of Blood Pressure Measured Casually and by Portable Recorders and Severity of Complications in Essential Hypertension , 1966, Circulation.
[22] R. D'Agostino,et al. Changes in risk factors and the decline in mortality from cardiovascular disease. , 1990, The New England journal of medicine.
[23] J. Chalmers,et al. Cross-over factorial studies with antihypertensive drugs. , 1987, Nephron.
[24] L. Cubeddu. Racial difference in response to antihypertensive drugs. A focus on verapamil. , 1986, Journal of clinical hypertension.
[25] B. Massie. Antihypertensive therapy with calcium-channel blockers: comparison with beta blockers. , 1985, The American journal of cardiology.
[26] W. J. Langford. Statistical Methods , 1959, Nature.